APP and Alzheimer disease: Accordingly, increasing evidence supports a role of astrocytes in AD onset and progression, as heralded by several morphological and molecular changes of astrocytes in AD mouse models (e.g. APP/PS1) and in human patients [6, 7] as well as by the link between Aβ plaques formation and changes in astrocytes morphology and activity [8, 9].